European Healthcare Acquisition & Growth Company B.V. / NL0015000K10
25.04.2024 - 16:25:04European Healthcare Acquisition & Growth Company B.V. publishes its Annual Report 2023
| European Healthcare Acquisition & Growth Company B.V. / Key word(s): Annual Report European Healthcare Acquisition & Growth Company B.V. publishes its Annual Report 2023 25.04.2024 / 16:25 CET/CEST The issuer is solely responsible for the content of this announcement. European Healthcare Acquisition & Growth Company B.V. publishes its annual report for the financial year 2023 Amsterdam, 25 April 2024 Today, European Healthcare Acquisition & Growth Company B.V. ("EHC"), a Dutch operators-led special purpose acquisition company listed on Euronext Amsterdam, publishes its annual report for the financial year 2023 (the "Annual Report 2023"), including its financial statements and the report of its board. The Annual Report 2023 relates to the financial year 2023, from 1 January 2023 to 31 December 2023, The Annual Report 2023 can be downloaded from the website of EHC in the 'Investor Relations' section under 'News & Publications', under 'Reports': www.ehc-company.com, where a downloadable version in the European Single Electronic Format (ESEF) is also available. The annual general meeting of shareholders of EHC will be held during the second half of Q2 2024, at which the Annual Report 2023 will be discussed. The agenda of the AGM will be published in due course. European Healthcare Acquisition & Growth Company B.V. General Enquiries +49 (0) 89 4523240 info@ehc-company.com Media Enquiries FGS Global Kai Peter Rath +49 211 43079-209 kai.rath@fgsglobal.com Disclaimer This press release, and the Annual Report 2023, may include forward-looking statements, which are based on EHC's current expectations and projections about future events and speak only as of the date hereof. By their nature, forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors because they relate to events and depend on circumstances that will occur in the future whether or not within or outside the control of EHC. Such factors may cause actual results, performance or developments to differ materially from those expressed or implied by such forward-looking statements. Accordingly, no undue reliance should be placed on any forward-looking statements. EHC operates in a rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible to predict all risks and uncertainties, nor to assess the impact that these factors will have on EHC. Forward-looking statements speak only as at the date at which they are made and EHC undertakes no obligation to update these forward-looking statements. Further reference is made to the risk factors in the Annual Report 2023. This press release contains information that may qualify as inside information within the meaning of Article 7, paragraph 1, of the EU Market Abuse Regulation. 25.04.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com |
| Language: | English |
| Company: | European Healthcare Acquisition & Growth Company B.V. |
| c/o ALR Treuhand GmbH; Theresienhöhe 28 | |
| 80339 München | |
| Germany | |
| ISIN: | NL0015000K10, NL0015000K28 |
| WKN: | A3C60V |
| Listed: | Regulated Unofficial Market in Frankfurt, Munich, Stuttgart; Amsterdam |
| EQS News ID: | 1888351 |
| End of News | EQS News Service |
| |
